[Treatment of catarrhal infections or influenza-like diseases with Fiobrol].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000700:Analgesics / Q000627:therapeutic use*; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D002110:Caffeine / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010653:Phenylbutazone / Q000627:therapeutic use*; D012141:Respiratory Tract Infections / Q000188:drug therapy*
D000700:Analgesics; D000893:Anti-Inflammatory Agents; D002110:Caffeine; D010653:Phenylbutazone
Zur Behandlung katarrhalischer Infekte bzw. grippeähnlicher Erkrankungen mit Fiobrol.